TIANJIN PHARM DA REN TANG GRP
(SGX: T14)

TIANJIN ZHONGXIN PHARMACEUTICAL GROUP CORPORATION LIMITED is a China-based company mainly engaged in the development, manufacture and distribution of pharmaceutical products. The Company’s main products include Chinese patent medicines, western medicines, Chinese medicinal materials, pharmaceutical raw materials and preparations, biological medicines, dietary supplements and other products. The Company’s main products consist of drugs for treatment of cardiovascular diseases and enterogastritis, respiratory drugs, as well as antineoplastic drugs, among others. It distributes its products within domestic market and to overseas markets.

3.200 -

+0.030 (+0.95%)
Range 3.140 - 3.210   (2.23%)
Open 3.170
Previous Close 3.170
Bid Price 3.200
Bid Volume ('000) 0.7
Ask Price 3.210
Ask Volume ('000) 2.5
Volume ('000) 69.2
Value 220,588
Remark -
Delayed prices. Updated at 05 Dec 2025 12:00.
Data powered by

Upcoming Events

EGM

Meeting Date 15 December 2025
Meeting Time 2:00 PM
2.00 P.M. AT AN EGM OF THE COMPANY WILL BE HELD AT THE MEETING ROOM OF DA REN TANG MANSION, TIANJIN, THE PRC 300193 (CONCURRENTLY, VIA VIDEO CONFERENCING AT NTUC CENTRE, 1 MARINA BOULEVARD, LEVEL 7, ROOM 701, SINGAPORE 018989 FOR HOLDERS OF THE S-SHARES ( S-SHARE SHAREHOLDERS ) IN SINGAPORE) ON MONDAY, 15 DECEMBER 2025 AT 2:00 P.M..

EGM

Meeting Date 15 December 2025
Meeting Time 2:00 PM
2.00 P.M. AT THE MEETING ROOM OF DA REN TANG MANSION, TIANJIN, THE PRC 300193. CONCURRENTLY, VIA VIDEO CONFERENCING AT NTUC CENTRE, 1 MARINA BOULEVARD, LEVEL 7, ROOM 701, SINGAPORE 018989 FOR HOLDERS OF THE S-SHARES ( S-SHARE SHAREHOLDERS ) IN SINGAPORE.
Data powered by SGX.
View Stock Calendar
View All Events

About TJ DaRenTang USD

TIANJIN ZHONGXIN PHARMACEUTICAL GROUP CORPORATION LIMITED is a China-based company mainly engaged in the development, manufacture and distribution of pharmaceutical products. The Company’s main products include Chinese patent medicines, western medicines, Chinese medicinal materials, pharmaceutical raw materials and preparations, biological medicines, dietary supplements and other products. The Company’s main products consist of drugs for treatment of cardiovascular diseases and enterogastritis, respiratory drugs, as well as antineoplastic drugs, among others. It distributes its products within domestic market and to overseas markets.

Loading Chart...

Please login to view stock data and analysis